Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Triple Negative Breast Neoplasms
×
Bevacizumab
×
30 days
×
Clear all
Filters
3
NCT05579366
2026-03-03
RAINFOL-01
Genmab
Phase 1/2
Recruiting
764 enrolled
NCT06976944
2026-02-23
PRELUDE
Japanese Foundation for Cancer Research
Phase 2
Recruiting
44 enrolled